ONWARD MEDICAL BV EO -12 (63E) — Tangible Net Worth Ratio
ONWARD MEDICAL BV EO -12 (63E) has a Tangible Net Worth Ratio of 87.4% as of December 2025. This metric is calculated by deducting intangible assets (€7.00 Million) from net assets (€55.32 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See what is ONWARD MEDICAL BV EO -12's book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
ONWARD MEDICAL BV EO -12 Tangible Net Worth Ratio (2021–2025)
This chart shows how ONWARD MEDICAL BV EO -12's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 87.4%, reflecting net assets of €55.32 Million with intangible assets of €7.00 Million EUR. Also explore net asset momentum of ONWARD MEDICAL BV EO -12 to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for ONWARD MEDICAL BV EO -12 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for ONWARD MEDICAL BV EO -12 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see ONWARD MEDICAL BV EO -12 (63E) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.4% | €55.32 Million | €7.00 Million | €84.55 Million | ▲ +5.0 pp |
| 2024 | 82.4% | €48.05 Million | €8.46 Million | €76.14 Million | ▲ +26.8 pp |
| 2023 | 55.6% | €17.93 Million | €7.96 Million | €43.63 Million | ▼ -28.7 pp |
| 2022 | 84.3% | €52.63 Million | €8.26 Million | €76.59 Million | ▼ -5.6 pp |
| 2021 | 89.9% | €82.68 Million | €8.33 Million | €104.80 Million | — |